Autoimmune lymphoproliferative syndrome other imaging findings
|
Autoimmune lymphoproliferative syndrome Microchapters |
|
Differentiating Autoimmune lymphoproliferative syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Autoimmune lymphoproliferative syndrome other imaging findings On the Web |
|
American Roentgen Ray Society Images of Autoimmune lymphoproliferative syndrome other imaging findings |
|
FDA on Autoimmune lymphoproliferative syndrome other imaging findings |
|
CDC on Autoimmune lymphoproliferative syndrome other imaging findings |
|
Autoimmune lymphoproliferative syndrome other imaging findings in the news |
|
Blogs on Autoimmune lymphoproliferative syndrome other imaging findings |
|
Directions to Hospitals Treating Autoimmune lymphoproliferative syndrome |
|
Risk calculators and risk factors for Autoimmune lymphoproliferative syndrome other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Fluorodeoxyglucose positron emission tomography (FDG-PET) may be helpful in the diagnosis of Autoimmune lymphoproliferative syndrome(ALPS) by distinguishing benign lymphadenopathy from malignant lymphadenopathy.
Other Imaging Findings
PET scan can be a useful tool to minimize the number of lymph nodes to get biopsied.[1]
References
- ↑ Rao, V. Koneti; Oliveira, João Bosco (2011). "How I treat autoimmune lymphoproliferative syndrome". Blood. 118 (22): 5741–5751. doi:10.1182/blood-2011-07-325217. ISSN 0006-4971.